ロード中...
Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia
Hereditary hemorrhagic telangiectasia (HHT), genetic disorder manifested by uncontrolled multisystem angiogenesis with epistaxis, gastrointestinal bleeding, iron-deficiency anaemia, and arteriovenous malformations (AVM) is often related with increased levels of vascular endothelial growth factor (VE...
保存先:
| 出版年: | Hum Vaccin Immunother |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514147/ https://ncbi.nlm.nih.gov/pubmed/25839219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1011960 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|